Accenture Ventures has invested in AlphaSense to integrate automated market intelligence workflows directly into enterprise corporate strategy. The partnership responds to an evolving corporate environment where 78% of C-suite leaders now view AI primarily as a tool for revenue growth rather than cost reduction. By embedding these capabilities, the companies aim to solve the persistent operational challenge of blending internal corporate data with external market insights.
The collaboration will deploy AlphaSense’s proprietary content library directly into Accenture’s client offerings. The platform continuously analyzes financial, market, and expert intelligence from a repository of 500 million business documents, broker research, and public filings. The initial rollout will target data-heavy sectors including financial services, life sciences, healthcare, technology, and energy.
AlphaSense enters the partnership with $600 million in ARR and a client roster that includes 90% of the S&P 100, all of the world's top global investment banks, and 92% of the world's 50 largest pharmaceutical companies. The enterprise intelligence platform also recently secured a $350 million funding round at a $7.5 billion valuation.
While financial terms of the investment remain undisclosed, the strategic rollouts are already moving forward. Manish Sharma, Chief Strategy and Services Officer at Accenture, stated that the integration empowers clients "to move beyond information processing to true enterprise intelligence." AlphaSense Founder and CEO Jack Kokko added that the alliance enables workflows that "turn intelligence into action."